Bristol-Myers Squibb Co. (BMY) PT Lowered to $63 at Morgan Stanley

May 2, 2022 2:23 AM EDT
Get Alerts BMY Hot Sheet
Price: $71.09 -0.86%

Rating Summary:
    12 Buy, 15 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 4 | New: 31
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $63.00 (from $64.00) while maintaining a Underweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change